NCT06964815 Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients Status RECRUITING Phase NA
NCT06936046 Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression Status RECRUITING Phase PHASE2
NCT06934889 Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma Status RECRUITING Phase PHASE1
NCT06929819 Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor Status NOT_YET_RECRUITING Phase NA
NCT06924099 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France) Status RECRUITING Phase N/A
NCT06831526 Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma Status RECRUITING Phase EARLY_PHASE1
NCT06804655 Pharmacoscopy for Patients With Refractory Primary Brain Tumors Status NOT_YET_RECRUITING Phase PHASE2
NCT06797661 Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. Status RECRUITING Phase NA
NCT06796335 Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour Status COMPLETED Phase N/A
NCT06782984 Drug Response Testing and Repurposing Using Glioblastoma Organoid Status RECRUITING Phase N/A
NCT06781372 Patient's Derived Organoids for Drug Screening in Glioblastoma Status NOT_YET_RECRUITING Phase NA
NCT06780592 Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery Status NOT_YET_RECRUITING Phase PHASE2
NCT06764537 Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma Status NOT_YET_RECRUITING Phase NA
NCT06749925 Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma Status NOT_YET_RECRUITING Phase PHASE3
NCT06719440 Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume Status RECRUITING Phase NA
NCT06710249 Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema Status RECRUITING Phase PHASE2
NCT06684899 Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients Status NOT_YET_RECRUITING Phase N/A